Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-11

Clinical Trial Update: Measurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to Biologics [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating structural efficacy of sarilumab with methotrexate in biologic-naive rheumatoid arthritis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sarilumab (sarilumab)

Snippet

Sponsor: Gaylis, Norman B., M.D. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: UNKNOWN